We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
58 hedge funds and large institutions have $56.7M invested in Corcept Therapeutics in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
38% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 16
4% more funds holding
Funds holding: 56 → 58 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $62.8M → $56.7M (-$6.02M)
Holders
58
Holders Change
+2
Holders Change %
+3.57%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
22
Reduced
16
Closed
2
Calls
$34K
Puts
–
Net Calls
+$34K
Net Calls Change
+$131K
Top Buyers
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$308K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$141K |
| 3 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$88.2K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$77.9K |
| 5 |
ISL
Ingalls & Snyder LLC
New York
|
+$61.9K |
